Clinical Trials Logo
  1. Home
  2. Community-Acquired Pneumonia
  3. NCT02139163
  4. Details
NCT02139163 Clinical Trial

Epidemiological Study on Community Acquired Pneumonia

Community Acquired Pneumonia Clinical Trial

— CAPNETZ  

Official title:
Epidemiological Study on Community Acquired Pneumonia

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02139163
Other study ID # U1111-1147-8393
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 2002
Est. completion date January 2022

Study information
Verified date July 2020
Source Hannover Medical School
Contact Tobias Welte, Prof.
Phone +49-511-532-5927
Email office@capnetz.de
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia.

Description:

Long-term objectives of the basic research part are improvement of CAP-management with respect to therapy, diagnosis and prevention to contribute to a better care of patients with pneumonia. The aim of the study CAPNETZ is to improve diagnosis, treatment and patient care.

Recruitment information / eligibility
Status Recruiting
Enrollment 10150
Est. completion date January 2022
Est. primary completion date January 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age = 18

- infiltrate on chest X-ray

- further Inclusion criteria: cough or production of purulent sputum or pathologic lung auscultation (crackles) or fever

Exclusion Criteria:

- hospital inpatient treatment within the last 28 days

- Immune suppressed patients

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Cohort Study

Locations
Country Name City State
Germany CAPNETZ FOUNDATION Hannover Medical School (MHH) Hannover Niedersachsen
Germany Hannover Medical School Hannover Niedersachsen

Sponsors (1)
Lead Sponsor Collaborator
Hannover Medical School

Country where clinical trial is conducted

Germany, 

References & Publications (6)

Ewig S, Klapdor B, Pletz MW, Rohde G, Schütte H, Schaberg T, Bauer TT, Welte T; CAPNETZ study group. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 2012 Feb;67(2):132-8. doi: 10.1136/thoraxjnl-2011-200630. Epu — View Citation

Klapdor B, Ewig S, Pletz MW, Rohde G, Schütte H, Schaberg T, Welte T; CAPNETZ Study Group. Community-acquired pneumonia in younger patients is an entity on its own. Eur Respir J. 2012 May;39(5):1156-61. doi: 10.1183/09031936.00110911. Epub 2011 Nov 16. Er — View Citation

Klapdor B, Ewig S, Schaberg T, Rohde G, Pletz MW, Schütte H, Welte T; CAPNETZ study group. Presentation, etiology and outcome of pneumonia in younger nursing home residents. J Infect. 2012 Jul;65(1):32-8. doi: 10.1016/j.jinf.2012.02.003. Epub 2012 Feb 10. — View Citation

Kolditz M, Höffken G, Martus P, Rohde G, Schütte H, Bals R, Suttorp N, Pletz MW; CAPNETZ study group. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort stud — View Citation

Lepper PM, Ott S, Nüesch E, von Eynatten M, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Jüni P, Bals R, Rohde G; German Community Acquired Pneumonia Competence Network. Serum glucose levels for predicting death in patients admitted to — View Citation

Zobel K, Martus P, Pletz MW, Ewig S, Prediger M, Welte T, Bühling F; CAPNETZ study group. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary diagnosis Assessment of diagnosis:
Patients will be asked for example, about their diagnosis, comorbidities, specific risk factors and pneumonia symptoms.		 2 weeks
Primary therapy Assessment of therapy:
Patients will be asked about their therapy due to pneumonia symptoms, previous therapy, medication History etc.		 2 weeks
Primary hospitalization Assessment of hospitalization:
Patients will be asked about hospitalization, date, time and duration of hospitalization due to pneumonia symptoms.		 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT02559310 - Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia Phase 3
Completed NCT01530763 - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) Phase 2/Phase 3
Completed NCT02517489 - Community-Acquired Pneumonia : Evaluation of Corticosteroids Phase 3
Not yet recruiting NCT01937832 - A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia Phase 3
Completed NCT02454114 - HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections N/A
Completed NCT00653172 - Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia Phase 2
Completed NCT03411824 - Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine
Recruiting NCT06210282 - The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice N/A
Withdrawn NCT02269644 - A P3 Comparator Trial in Community Acquired Bacterial Pneumonia Phase 3
Recruiting NCT01963442 - Short Duration Treatment of Non-severe Community Acquired Pneumonia Phase 2
Terminated NCT00887276 - Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia Phase 4
Not yet recruiting NCT00390819 - Epidemiology of Community Acquired Pneumonia in North Israel N/A
Completed NCT00079885 - Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia Phase 3
Not yet recruiting NCT04158310 - Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
Recruiting NCT02552342 - Corticosteroid Therapy for Severe Community-Acquired Pneumonia Phase 4
Completed NCT02922387 - Smoking Cessation Intervention in Respiratory Inpatients Phase 4
Completed NCT00467701 - Community Acquired Pneumonia in Telemark and Ostfold N/A
Completed NCT04198571 - Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
Completed NCT02107001 - Lung Ultrasound in Pleuritic Chest Pain N/A
Completed NCT01561885 - Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways N/A

External Links